Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: NK/T-cell lymphoma | Statement: [CD38, therapeuticArea, NK/T-cell lymphoma]

Target entity: NK/T-cell lymphoma
Context triple: [CD38, therapeuticArea, NK/T-cell lymphoma]

• A. Hodgkin lymphoma
  Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
• B. non-Hodgkin lymphoma
  Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
• C. Hodgkin
  Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
• D. CLL
  CLL is the IATA airport code for Easterwood Airport, a regional airport serving College Station, Texas.
• E. chronic lymphocytic leukemia
  Chronic lymphocytic leukemia is a slow-growing cancer of the blood and bone marrow characterized by an overproduction of abnormal lymphocytes, most commonly affecting older adults.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: NK/T-cell lymphoma
Triple: [CD38, therapeuticArea, NK/T-cell lymphoma]

NK/T-cell lymphoma is a rare, aggressive non-Hodgkin lymphoma arising from natural killer cells or cytotoxic T cells, often associated with Epstein–Barr virus and frequently involving the nasal cavity and upper aerodigestive tract.

Target entity: NK/T-cell lymphoma
Target entity description: NK/T-cell lymphoma is a rare, aggressive non-Hodgkin lymphoma arising from natural killer cells or cytotoxic T cells, often associated with Epstein–Barr virus and frequently involving the nasal cavity and upper aerodigestive tract.

• A. Hodgkin lymphoma
  Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
• B. non-Hodgkin lymphoma chosen
  Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
• C. Hodgkin
  Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
• D. CLL
  CLL is the IATA airport code for Easterwood Airport, a regional airport serving College Station, Texas.
• E. chronic lymphocytic leukemia
  Chronic lymphocytic leukemia is a slow-growing cancer of the blood and bone marrow characterized by an overproduction of abnormal lymphocytes, most commonly affecting older adults.
• F. None of above.